enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis fought a seven-year, controversial battle to patent Gleevec in India, and took the case all the way to the Indian Supreme Court, where the patent application was finally rejected. The patent application at the center of the case was filed by Novartis in India in 1998, after India had agreed to enter the World Trade Organization and to ...

  3. Novartis v. Union of India & Others - Wikipedia

    en.wikipedia.org/wiki/Novartis_v._Union_of_India...

    Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent Gleevec in India, and was the culmination of a seven-year-long litigation fought by Novartis. The Supreme Court upheld the Indian patent office's rejection of the patent application.

  4. Evergreening - Wikipedia

    en.wikipedia.org/wiki/Evergreening

    Novartis v. Union of India & Others is a landmark decision, in which Indian Supreme Court upheld rejection of Novartis patent by Indian patent office. The key basis for the rejection was the part of Indian patent law that was created by amendment in 2005, describing the patentability of new uses for known drugs and modifications of known drugs.

  5. Proprietary drug - Wikipedia

    en.wikipedia.org/wiki/Proprietary_drug

    Novartis had filed a patent for Glivec in 1997. [30] An exclusive marketing right was also granted for Novartis in 2003 and the application were approved in 2005 . [ 30 ] In 2013, the Supreme Court of India upheld the rejection of the patent application of Glivec by Novartis , [ 31 ] ending the 10-years battle between the proprietary drug ...

  6. Sandoz - Wikipedia

    en.wikipedia.org/wiki/Sandoz

    Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz.

  7. Discovery and development of dipeptidyl peptidase-4 inhibitors

    en.wikipedia.org/wiki/Discovery_and_development...

    Ferring Pharmaceuticals filed for patent on two cyanopyrrolidine DPP-4 inhibitors, which they published in 1995. These compounds had excellent potency and improved chemical stability. In 1995, Edwin B. Villhauer at Novartis started to explore N-substituted glycinyl-cyanopyrrolidines based on the fact that DPP-4 identifies N-methylglycine as an ...

  8. Category:Drugs developed by Novartis - Wikipedia

    en.wikipedia.org/wiki/Category:Drugs_developed...

    View history; General What links here; Related changes; Upload file; Special pages; Permanent link; Page information; Get shortened URL; Download QR code ...

  9. Patents for Humanity - Wikipedia

    en.wikipedia.org/wiki/Patents_for_Humanity

    Novartis AG for innovation in treatments for drug-resistant tuberculosis, donated to the TB Alliance; Sanitation. American Standard Brands – for SaTo, a safe toilet; Nutrition. Golden rice – a strain of rice high in beta-carotene to reduce Vitamin A deficiency. Nutriset – manufacturer of Plumpy'nut, a peanut-based paste to treat ...